Controlled glycosylation of therapeutic antibodies in plants.
Recombinant therapeutic monoclonal antibodies (mAb) can be expressed, assembled, and glycosylated in plants. Transgenic plants, producing anti-rabies mAb and anti-colorectal cancer mAb, were obtained from Agrobacterium-mediated transformation. The heavy chain (HC) of anti-rabies mAb was fused to the...
Päätekijät: | Tekoah, Y, Ko, K, Koprowski, H, Harvey, D, Wormald, M, Dwek, R, Rudd, P |
---|---|
Aineistotyyppi: | Journal article |
Kieli: | English |
Julkaistu: |
2004
|
Samankaltaisia teoksia
-
Glycosylation and prion protein.
Tekijä: Rudd, P, et al.
Julkaistu: (2002) -
Exploring functions for glycosylation in host defence using novel oligosaccharide sequencing technology
Tekijä: Rudd, P, et al.
Julkaistu: (2000) -
Glycosylation changes on serum glycoproteins in ovarian cancer may contribute to disease pathogenesis.
Tekijä: Saldova, R, et al.
Julkaistu: (2008) -
O-linked glycosylation in focus
Tekijä: Van den Steen, P, et al.
Julkaistu: (2000) -
The impact of glycosylation on the biological function and structure of human immunoglobulins.
Tekijä: Arnold, J, et al.
Julkaistu: (2007)